Litcius/Paper detail

Optical See-through Head-mounted Display (OST-HMD)–assisted Needle Biopsy for Breast Tumor: A Technical Innovation

Shinichiro Kashiwagi, Yuka Asano, Wataru Goto, Tamami Morisaki, Masatsune Shibutani, Hiroaki Tanaka, Kosei Hirakawa, Masaichi Ohira

2022In Vivo10 citationsDOIOpen Access PDF

Abstract

BACKGROUND/AIM: Augmented reality (AR) is a new technology that provides new awareness by using a computer to extend the real environment perceived by humans. Optical see-through head-mounted displays (OST-HMD) are worn on the head and can faithfully generate an AR image by wearing the device on the head as a spectacle-type device. We developed an ultrasound-guided needle biopsy technique using OST-HMD for breast tumors. PATIENTS AND METHODS: Moverio BT-35E (Seiko Epson Corp, Nagano, Japan) was used as the OST-HMD device. This technique involves performing needle biopsy under direct vision via the gap at the bottom of the display while the ultrasound images are projected on the display of the OST-HMD worn on the head. RESULTS: With this technique, needle biopsy can be executed smoothly with no posture restrictions. A flip shade affixed to the OST-HMD has 2% transmittance, which enables clearer projection of the images. CONCLUSION: This article outlines the ultrasound-guided needle biopsy using OST-HMD. We established a safe and accurate biopsy technique with technological innovations using AR.

Topics & Concepts

Augmented realityBiopsyOptical head-mounted displayComputer scienceUltrasoundMedicineHead (geology)Computer visionRadiologyGeologyGeomorphologyAugmented Reality ApplicationsAdvances in Oncology and RadiotherapyOphthalmology and Visual Health Research
Optical See-through Head-mounted Display (OST-HMD)–assisted Needle Biopsy for Breast Tumor: A Technical Innovation | Litcius